| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Arthur Riggs last filed a Form 4 in December 2018, as 10% Owner at LIXT. Arthur Riggs's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 6,110,000 shares of LIXT. Net of sales, the LIXT filings show accumulation of 1,260,000 shares.
Arthur Riggs has 3 Form 4 filings on record from March 2015 to December 2018, all as 10% Owner at Lixte Biotechnology (LIXT), 2015–2018.
The 4 reported transactions were 4 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $630K and no sales.
The only open-market purchase was 1,260,000 shares of LIXT at an average $0.50 on December 7, 2018, about $630K.
Shares as reported in the last Form 4 for each company; the most recent is from December 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2018 | LIXT Lixte Biotechnology Holdings, Inc. | 10% Owner | Buy | 1,260,000 | $0.50 | $630,000.00 | +26.0% |